NCT06270459 Telerehabilitation Robotics for Upper Limb Rehabilitation After STroke
| NCT ID | NCT06270459 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tan Tock Seng Hospital |
| Condition | Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 54 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2025-08-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 54 participants in total. It began in 2024-11-01 with a primary completion date of 2025-08-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There has been an observed decrease in motor and functional ability and non-use of the impaired limb in chronic patients. This is due to the immediate drop in intensive daily therapy (5 days per week for 3 hours/day) that is usually provided during the inpatient (acute) phase upon discharge from the hospital. In this study, the investigators plan to address the low dosage of therapy in the post-acute discharge phase for stroke survivors.
Eligibility Criteria
Inclusion Criteria: 1. Clinical stroke (ischaemic or haemorrhagic) confirmed by admitting doctors and CT, CT angiography or MRI brain imaging. 2. Age 21 to 90 years, both males and females. 3. At least \> 28 days post stroke. 4. Upper limb motor impairment of Fugl-Myer Motor Assessment (FMA) scale 10 to 60 5. Has a stable home abode and a carer/ NOK to supervise home based exercise. 6. Ability to sit supported continuously for 60 minutes. 7. Montreal Cognitive Assessment (MOCA) score \> 21/30 8. Able to understand purpose of research and give consent. Exclusion Criteria: 1. Non-stroke related causes of arm motor impairment. 2. Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, ischaemic heart disease, congestive heart failure, bronchial asthma, end stage renal/liver/heart/lung failure, unresolved cancers. 3. Anticipated life expectancy of \< 6 months. 4. Inability to tolerate sitting continuously for 60 minutes. 5. Local factors potentially worsened by intensive robot-aided arm therapy and computer-based training: active seizures within 3 months, spasticity of Modified Ashworth Scale grades \>2 skin wounds, shoulder, arm pain VAS \> 5/10, active upper limb fractures, arthritis, fixed upper limb flexion contractures. 6. Hemianesthesia of affected limb. 7. History of dementia, severe depression, agitation, or behavioural problems. 8. Pregnancy or lactation in females 9. Absence of reliable carer to provide supervision during home training
Contact & Investigator
Karen Chua
PRINCIPAL INVESTIGATOR
Tan Tock Seng Hospital
Frequently Asked Questions
Who can join the NCT06270459 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 90 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06270459 currently recruiting?
Yes, NCT06270459 is actively recruiting participants. Contact the research team at Jaclyn_AM_LOW@ttsh.com.sg for enrollment information.
Where is the NCT06270459 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT06270459 clinical trial?
NCT06270459 is sponsored by Tan Tock Seng Hospital. The principal investigator is Karen Chua at Tan Tock Seng Hospital. The trial plans to enroll 54 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.